02Dec 2021
COVID‐19 vaccine acceptance and hesitancy in patients with immunobullous diseases: a cross‐sectional study of the International Pemphigus and Pemphigoid Foundation

COVID‐19 vaccine acceptance and hesitancy in patients with immunobullous diseases: a cross‐sectional study of the International Pemphigus and Pemphigoid Foundation

Patients with autoimmune bullous diseases (AIBDs) have faced considerable challenges during the COVID‐19 outbreak.SARS‐CoV‐2 vaccines became an important public health solution, but the pandemic raised awareness of vaccine hesitancy.We aimed to investigate the currently unknown general vaccination status among AIBD patients to better inform vaccine practices in this cohort of potentially life‐threatening inflammatory disorders...

  • #dermatology

Like

Save

Share